Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connor J Lewis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
A Case for Automated Segmentation of MRI Data in Milder Neurodegenerative DiseasesConnor J Lewis, Jean M Johnston, Precilla D'Souza, et al.
Neurosci|April 23, 2025
A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 GangliosidosisConnor J Lewis, Jean M Johnston, Precilla D'Souza, et al.
Medrxiv : the Preprint Server for Health Sciences|September 19, 2025
Similarities and Differences in the Late-Onset GM2 Gangliosidoses: Tay-Sachs and Sandhoff DiseasesConnor J Lewis, Leila Shirvan, Jean M Johnston, et al.
Molecular Genetics and Metabolism|January 28, 2025
Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patientsJosephine Kolstad, Christopher Zoppo, Jean M Johnston, et al.
Molecular Genetics and Metabolism|April 17, 2025
Corrigendum to "Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients" [Molecular Genetics and Metabolism 2025 Mar;144(3):109025]Josephine Kolstad, Christopher Zoppo, Jean M Johnston, et al.
The New England Journal of Medicine|February 10, 2026
AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 TrialConnor J Lewis, Precilla D'Souza, Jean M Johnston, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
AAV9 Gene Therapy in GM1 Gangliosidosis Type II: A Phase 1/2 TrialConnor J Lewis, Precilla D'Souza, Jean M Johnston, et al.
Nature Medicine|August 15, 2025
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trialFlorian Eichler, Oguz I Cataltepe, Rrita Daci, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
A Case for Automated Segmentation of MRI Data in Milder Neurodegenerative DiseasesConnor J Lewis, Jean M Johnston, Precilla D'Souza, et al.
Neurosci|April 23, 2025
A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 GangliosidosisConnor J Lewis, Jean M Johnston, Precilla D'Souza, et al.
Medrxiv : the Preprint Server for Health Sciences|September 19, 2025
Similarities and Differences in the Late-Onset GM2 Gangliosidoses: Tay-Sachs and Sandhoff DiseasesConnor J Lewis, Leila Shirvan, Jean M Johnston, et al.
Molecular Genetics and Metabolism|January 28, 2025
Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patientsJosephine Kolstad, Christopher Zoppo, Jean M Johnston, et al.
Molecular Genetics and Metabolism|April 17, 2025
Corrigendum to "Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients" [Molecular Genetics and Metabolism 2025 Mar;144(3):109025]Josephine Kolstad, Christopher Zoppo, Jean M Johnston, et al.
The New England Journal of Medicine|February 10, 2026
AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 TrialConnor J Lewis, Precilla D'Souza, Jean M Johnston, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
AAV9 Gene Therapy in GM1 Gangliosidosis Type II: A Phase 1/2 TrialConnor J Lewis, Precilla D'Souza, Jean M Johnston, et al.
Nature Medicine|August 15, 2025
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trialFlorian Eichler, Oguz I Cataltepe, Rrita Daci, et al.
Pageof 2